Nanomaterials in combating cancer: Therapeutic applications and developments

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 1, 2014, Pages 19-34

  Nazir, Samina ^a   Hussain, Tajammul ^a   Ayub, Attiya ^a,b   Rashid, Umer ^b   MacRobert, Alexander John ^c  

^a NATIONAL CENTRE FOR PHYSICS   (Pakistan)

^b HAZARA UNIVERSITY   (Pakistan)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AuNPs; Cancer; Nanoparticles; Polymeric nanoparticles; Qdots

Indexed keywords

ANTI-CANCER THERAPIES; AUNPS; CANCER; PHYSICOCHEMICAL PROPERTY; POLYMERIC NANOPARTICLES; QDOTS; THERAPEUTIC APPLICATION; THERAPEUTIC TECHNIQUES;

BIOCOMPATIBILITY; DIAGNOSIS; DISEASES; NANOPARTICLES; POLYMERS; TUMORS;

NANOSTRUCTURED MATERIALS;

DENDRIMER; FULLERENE DERIVATIVE; GOLD NANOPARTICLE; LIPOSOME; NANOMATERIAL; NANOSPHERE; QUANTUM DOT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

CANCER DIAGNOSIS; CANCER THERAPY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; IN VIVO STUDY; MICELLE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; REVIEW; SYNTHESIS;

AUNPS; CANCER; NANOPARTICLES; POLYMERIC NANOPARTICLES; QDOTS;

ANTINEOPLASTIC AGENTS; HUMANS; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; POLYMERS;

EID: 84890996933     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.07.001     Document Type: Review

References (145)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer. The next generation. Cell 2011, 144:646-674.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
3. Chen P.C., Mwakwari S.C., Oyelere A.K. Gold nanoparticles: from nanomedicine to nanosensing. Nanotechnology: Science and Applications 2008, 1:45-66.
4. Muthu M.S., Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 2009, 4:105-118.
5. Janib S.M., Moses A.S., MacKay J.A. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 2010, 62:1052-1063.
6. Grossman J.H., Scott E., McNei S.E. Nanotechnology in cancer medicine. Phys Today 2012, 65:38-42.
7. Huang H.C., Barua S., Sharma G., Dey S.K., Rege K. Inorganic nanoparticles for cancer imaging and therapy. J Control Release 2011, 155:344-357.
8. Namiki Y., Fuchigami T., Tada N., Kawamura R., Matsunuma S., Kitamoto Y., Nakagawa M. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Acc Chem Res 2011, 44:1080-1093.
9. Danquah M.K., Zhang X.A., Mahato R.I. Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev 2011, 63:623-639.
10. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumours. Nat Rev Clin Oncol 2010, 7:653-664.
11. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009, 71:409-419.
12. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011, 63:136-151.
13. Nanomaterials for cancer diagnosis. Nanotechnologies for the Life Sciences 2007, Vol. 7. WILEY-VCH Verlag GmbH & Co KGaA, ISBN:, Weinheim. C.S.S.R. Kumar (Ed.).
14. Ruoslahti E., Bhatia S.N., Sailor M.J. Targeting of drugs and nanoparticles to tumours. JCB 2010, 188:759-768.
15. Qiao W., Wang B., Wang Y., Yang L., Zhang Y., Shao P. Cancer therapy based on nanomaterials and nanocarrier systems. J Nanomaterials 2010, Article ID 796303. doi:10.1155/2010/796303.
16. Boas U., Heegaard P.M.H. Dendrimers in drug research. Chem Soc Rev 2004, 33:43-63.
17. Onitsuka K., Fujimoto M., Kitajima H., Ohshiro N., Takei F., Takahashi S. Convergent synthesis of platinum-acetylide dendrimers. Chem Eur J 2004, 10:6433-6446.
18. Cheng Y., Zhao L., Lic Y., Xu T. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem Soc Rev 2011, 40:2673-2703.
19. Jain N.K., Tekade R.K. Dendrimers for enhanced drug solubilization Douroumis D, Fahr A, editors 2013, Drug Delivery Strategies for Poorly Water-Soluble Drugs, John Wiley & Sons Ltd, Oxford, UK. 10.1002/9781118444726.ch13.
20. Jaracz S., Chen J., Kuznetsova L.V., Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005, 13:5043-5054.
21. Choi Y., Thomas T., Kotlyar A., Islam M.T., Baker J.R. Synthesis and functional evaluation of DNA-assembled polyamidoamine (PAMAM) dendrimer clusters with cancer cell-specific targeting. Chem Biol 2005, 12:35-43.
22. Clementi C., Miller K., Mero A., Satchi-Fainaro R., Pasut G. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms. Mol Pharm 2011, 8:1063-1072.
23. Kobayashi H., Brechbiel M.W. Dendrimer-based macromolecular MRI contrast agents Characteristics and application. Mol Imaging 2003, 2:1-10.
24. Barth R.F., Wu G., Yang W., Binns P.J., Riley K.J., Patel H., et al. Neutron capture therapy of epidermal growth factor ({thorn}) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Appl Radiat Isot 2004, 61:899-903.
25. Lin Y.-Y., Kao H.-W., Li J.-J., Hwang J.-J., Tseng Y.-L., Lin W.-J., et al. Tumor burden talks in cancer treatment with PEGylated liposomal drugs. PLoS One 2013, 8:e63078. 10.1371/journal.pone.0063078.
26. Felber A.E., Dufresne M.H., Leroux J.C. PH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 2012, 64:979-992.
27. Roux E., Francis M.F., Winnik F.M., Leroux J.C. Stimuli responsive liposome-polymer complexes: towards the design of intelligent drug carriers. Carrier based drug delivery systems 2004, CS Symposium Series 879, American Chemical Society, Washington, DC. S. Svenson (Ed.).
28. Slingerland M., Guchelaar H.-J., Gelderblom H. Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Disc Today 2012, 17:160-166.
29. Yano J., Hirabayashi K., Nakagawa S.I., Yamaguchi T., Nogawa M., Kashimori I., et al. Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res 2004, 10:7721-7726.
30. Mukherje A., Prasad T.K., Rao N.M., Banerjee R. Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells. J Biol Chem 2005, 280:15619-15627.
31. Viglianti B.L., Abraham S.A., Michelich C.R., Yarmolenko P.S., MacFall J.R., Bally M.B., Dewhirst M.W. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magn Resonan Imag 2004, 51:1153-1162.
32. Massignani M., Lomas H., Battaglia G. Polymersomes: a synthetic biological approach to encapsulation and delivery. Adv Polym Sci 2010, 229:115-154.
33. Lomas H., Canton I., MacNeil S., Du J., Armes S.P., Ryan A.J., et al. Biomimetic pH sensitive polymersomes for efficient DNA encapsulation and delivery. Adv Mater 2007, 19:4238-4243.
34. Sanson C., Schatz C., Le Meins J.F., BrÛlet A., Soum A., Lecommandoux S. Biocompatible and biodegradable poly(trimethylene carbonate)-b-poly(L-glutamic acid) polymersomes: size control and stability. Langmuir 2009, 26:2751-2760.
35. Upadhyay K.K., Mishra A.K., Chuttani K., Kaul A., Schatz C., Le Meins J.F., et al. The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl L-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice. Nanomedicine 2012, 8:71-80.
36. Miyata K., Christie R.J., Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym 2011, 71:227-234.
37. Bronich T.K., Keifer P.A., Shlyakhtenko L.S., Kabanov A.V. Polymer micelle with cross-linked ionic core. J Am Chem Soc 2005, 127:8236-8237.
38. Oberoi H.S., Laquer F.C., Marky L.A., Kabanov A.V., Bronich T.K. Core cross-linked block ionomer micelles as pH-responsive carriers for cis-diamminedichloro platinum(II). J Control Release 2011, 153:64-72.
39. Yuan X., Yamasaki Y., Harada A., Kataoka K. Characterization of stable lysozyme entrapped polyion complex (PIC) micelles with crosslinked core by glutaraldehyde. Polymer 2005, 46:7749-7758.
40. Yessine M.A., Dufresne M.H., Meier C., Petereit H.U., Leroux J.C. Proton-actuated membrane-destabilizing polyion complex micelles. Bioconjugate Chem 2007, 18:1010-1014.
41. Bayo-Puxan N., Dufresne M.H., Felber A.E., Castagner B., Leroux J.C. Preparation of polyion complex micelles from poly(ethylene glycol)-block-polyions. J Control Release 2011, 156:118-127.
42. Felber A.E., Castagner B., Elsabahy M., Deleavey G., Damha M.J., Leroux J.C. siRNA nanocarriers based on methacrylic acid copolymers. J Control Release 2011, 152:159-167.
43. Elsabahy M., Wazen N., Puxan N.B., Deleavey G., Servant M., Damha M.J., et al. Delivery of nucleic acids through the controlled disassembly of multifunctional nanocomplexes. Adv Funct Mater 2009, 19:3862-3867.
44. Shaji J., Patole V. Protein and peptide drug delivery: oral approaches. Indian J Pharm Sci 2008, 70:269-277.
45. Zhang T., Sturgis T.F., Youan B.B.C. pH-responsive nanoparticles releasing tenofovir for the prevention of HIV transmission. Eur J Pharm Biopharm 2011, 79:526-536.
46. Wang X.Q., Dai J.D., Zhang H., Zhang X., Wang J.C., Zhang Q. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol 2008, 8:2422-2431.
47. Sonaje K., Lin K.J., Wang J.J., Mi F.L., Chen C.T., Juang J.H., Sung H.W. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv Funct Mater 2010, 20:3695-3700.
48. Sonaje K., Chen Y.J., Chen H.L., Wey S.P., Juang J., Nguyen H.N., Hsu C.W., Lin K.J., Sung H.W. Enteric-coated capsules filled with freeze-dried chitosan/poly(γ-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 2010, 31:3384-3394.
49. Bosi S., Ros T.D., Spalluto G., Prato M. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 2003, 38:913-923.
50. Mikawa M., Kato H., Okamura M., Mi Narazak, Kanazawa Y., Miwa N., Shinohara H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem 2001, 12:510-514.
51. Toth E., Bolskar R.D., Borel A., Gonzalez G., Helm L., Merbach A.E., et al. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc 2005, 127:799-805.
52. Wang Y., Chen L. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine:NBM 2011, 7:385-402.
53. Alivisatos A.P. Semiconductor clusters, nanocrystals, and quantum dots. Science 1996, 271:933-937.
54. Xie J., Lee S., Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010, 62:1064-1079.
55. Santra S., Yang H.S., Holloway P.H., Stanley J.T., Mericle R.A. Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS:Mn/ZnS quantum dots: a multifunctional probe for bioimaging. J Am Chem Soc 2005, 127:1656-1657.
56. Santra S., Yang H., Dutta D., Stanley J.T., Holloway P.H., Tan W., et al. TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem Commun 2004, 2810-2811. 10.1039/B411916A.
57. Pinaud F., King D., Moore H.P., Weiss S. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. J Am Chem Soc 2004, 126:6115-6123.
58. Hanaki K., Momo A., Oku T., Komoto A., Maenosono S., Yamaguchi Y., et al. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun 2003, 302:496-501.
59. Lidke D.S., Nagy P., Heintzmann R., Arndt-Jovin D.J., Post J.N., Grecco H.E., et al. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol 2004, 22:198-203.
60. Morgan N.Y., English S., Chen W., Chernomordik V., Russo A., Smith P.D., et al. Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots. Acad Radiol 2005, 12:313-323.
61. Diagaradjane P., Orenstein-Cardona J.M., Colon-Casasnovas N.E., Deorukhkar A., Shentu S., Kuno N., et al. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe. Clin Cancer Res 2008, 14:731-741.
62. Hu R., Yong K.T., Roy I., Ding H., Law W.C., Cai H.X., et al. Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging. Nanotechnology 2010, 21:145105. 10.1088/0957-4484/21/14/145105.
63. Gao X., Yang L., Petros J.A., Marshall F.F., Simons J.W., Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005, 16:63-72.
64. Tada H., Higuchi H., Wanatabe T.M., Ohuchi N. In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumours of mice. Cancer Res 2007, 67:1138-1144.
65. Yang L.L., Mao H., Wang Y.A., Cao Z.H., Peng X.H., Wang X.X., et al. Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small 2009, 5:235-243.
66. Schroeder J.E., Shweky I., Shmeeda H., Banin U., Gabizon A. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles. J Control Release 2007, 124:28-34.
67. Cai W.B., Shin D.W., Chen K., Gheysens O., Cao Q.Z., Wang S.S., et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.
68. Zintchenko A., Susha A.S., Concia M., Feldmann J., Wagner E., Rogach A.L., et al. Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Mol Ther 2009, 17:1849-1856.
69. Jiang G., Park K., Kim J., Kim K.S., Hahn S.K. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol Pharm 2009, 67:727-737.
70. Gao J.H., Chen K., Xie R.G., Xie J., Lee S., Cheng Z., et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small 2010, 6:256-261.
71. 2/ZnS core/shell nanocrystals: cadmium-free quantum dots for in vivo imaging. Chem Mater 2009, 21:2422-2429.
72. Tu C.Q., Ma X.C., Pantazis P., Kauzlarich S.M., Louie A.Y. Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. J Am Chem Soc 2010, 132:2016-2023.
73. Kievit F.M., Zhang M. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 2011, 44:853-862.
74. Harisinghani M.G., Weissleder R. Sensitive, noninvasive detection of lymph node metastases. PLoS Med 2004, 1:e66.
75. Harisinghani M.G., Barentsz J., Hahn P.F., Deserno W.M., Tabatabaei S., van de Kaa C.H., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003, 348:2491-2499.
76. Liu F., Laurent S., Fattahi H., Elst L.V., Muller R.N. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. Nanomedicine (Lond) 2011, 6:519-528.
77. Mahmoudi M., Serpooshan V., Laurent S. Engineered nanoparticles for biomolecular imaging. Nanoscale 2011, 3:3007-3026.
78. Yallapu M.M., Othman S.F., Curtis E.T., Gupta B.K., Jaggi M., Chauhan S.C. Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy. Biomaterials 2011, 32:1890-1895.
79. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4:372-379.
80. Zhang C., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007, 67:1555-1562.
81. Johannsen M., Gneveckow U., Taymoorian K., Thiesen B., Waldofner N., et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia 2007, 23:315-323.
82. Banerjee R., Katsenovich Y., Lagos L., McIintosh M., Zhang X., Li C.Z. Nanomedicine: magnetic nanoparticles and their biomedical applications. Curr Med Chem 2010, 17:3120-3141.
83. Amstad E., Textor M., Reimhult E. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale 2011, 3:2819-2843.
84. Taylor R.M., Sillerud L.O. Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner. Int J Nanomed 2012, 7:4341-4352.
85. 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 2011, 32:4151-4160.
86. Thakor A.S., Jokerst J., Zavaleta C., Massoud T.F., Gambhir S.S. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 2011, 11:4029-4036.
87. Dykman L.A., Khlebtsov N.G. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae 2011, 3:34-55.
88. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticles for biology and medicine. Angew Chem Int Ed 2010, 49:3280-3294.
89. Oh E., Susumu K., Goswami R., Mattoussi H. One-phase synthesis of water-soluble gold nanoparticles with control over size and surface functionalities. Langmuir 2010, 26:7604-7613.
90. Huang X., Li B., Zhang H., Hussain I., Liang L., Tan B. Facile preparation of size-controlled gold nanoparticles using versatile and end-functionalized thioether polymer ligands. Nanoscale 2011, 3:1600-1607.
91. Jana N.R., Gearheart L., Murphy C.J. Seed-mediated growth approach for shape-controlled synthesis of spheroidal and rodlike gold nanoparticles using a surfactant template. J Adv Mater 2001, 13:1389-1393.
92. Sun Y., Xia Y. Shape-controlled synthesis of gold and silver nanoparticles. Science 2002, 298:2176-2179.
93. Sau T.K., Murphy C.J. Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution. J Am Chem Soc 2004, 126:8648-8649.
94. Kundu S., Panigrahi S., Praharaj S., Basu S., Ghosh S.K., Pal A., et al. Anisotropic growth of gold clusters to gold nanocubes under UV irradiation. Nanotechnology 2007, 18:075712. 10.1088/0957-4484/18/7/075712.
95. Mitra R.N., Das P.K. In situ preparation of gold nanoparticles of varying shape in molecular hydrogel of peptide amphiphiles. J Phys Chem C 2008, 112:8159-8166.
96. He S., Guo Z., Zhang Y., Zhang S., Wang J., Gu N. Biosynthesis of gold nanoparticles using the bacteria Rhodopseudomonas capsulate. Mat Lett 2007, 61:3984-3987.
97. Pyrpassopoulos S., Niarchos D., Nounesis G., Boukos N., Zafiropoulou I., Tzitzios V. Synthesis and self organization of Au nanoparticles. Nanotechnology 2007, 18:485604. 10.1088/0957-4484/18/48/485604.
98. Kundu S., Peng L., Liang H. A new route to obtain high-yield multiple-shaped gold nanoparticles in aqueous solution using microwave radiation. Inorg Chem 2008, 47:6344-6352.
99. Chauhan A., Zubair S., Tufail S., Sherwani A., Sajid M., Raman S.C., et al. Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer. Int J Nanomedicine 2011, 6:2305-2319.
100. Reddy V., Torati R.S., Oh S., Kim C. Biosynthesis of gold nanoparticles assisted by Sapindus mukorossi Gaertn. Fruit pericarp and their catalytic application for the reduction of p-nitroaniline. Ind Eng Chem Res 2013, 52:556-564.
101. Dreaden E.C., El-Sayed M.A. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Acc Chem Res 2012, 45:1854-1865.
102. Sharma P., Brown S., Walter G., Santra S., Moudgil B. Nanoparticles for bioimaging. Adv Colloid Interface Sci 2006, 123-126:471-485. 10.1016/j.cis.2006.05.026.
103. Khlebtsov N.G., Trachuk L.A., Mel'nikov A.G. The effect of the size, shape, and structure of metal nanoparticles on the dependence of their optical properties on the refractive index of a disperse medium. Opt Spectrosc 2005, 98:83-90.
104. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
105. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., et al. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
106. Qian W., Huang X., Kang B., El-Sayed M.A. Dark-field light scattering imaging of living cancer cell component from birth through division using bioconjugated gold nanoprobes. J Biomed Opt 2010, 15:1-9.
107. Kang B., Mackey M.A., El-Sayed M.A. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 2010, 132:1517-1519.
108. Agarwal A., Huang S.W., O'Donnell M., Day K.C., Day M., Kotov N., et al. Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging. J Appl Phys 2007, 102:064701. 10.1063/1.2777127.
109. Durr N.J., Larson T., Smith D.K., Korgel B.A., Sokolov K., Ben-Yakar A. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett 2007, 7:941-945.
110. Reuveni T., Motiei M., Romman Z., Popovtzer A., Popovtzer R. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomedicine 2011, 6:2859-2864.
111. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011, 6:715-728.
112. Rand D., Ortiz V., Liu Y., Derdak Z., Wands J.R., Tatícek M., et al. Nanomaterials for X-ray imaging: gold nanoparticle enhancement of x-ray scatter imaging of hepatocellular carcinoma. Nano Lett 2011, 11:2678-2683.
113. Sadowski E.A., Bennett L.K., Chan M.R., Wentland A.L., Garrett A.L., Garrett R.W., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007, 243:148-157.
114. Jaganathan H., Daniel L., Ivanisevic H.A. Examining MRI contrast in three-dimensional cell culture phantoms with DNA-templated nanoparticle chains. ACS Appl Mater Interfaces 2011, 3:1282-1288.
115. Barros A.L., Tsourkas A., Saboury B., Cardoso V.N., Alavi A. Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res 2012, 2:39. 10.1186/2191-219X-2-39.
116. Morales-Avila E., Ferro-Flores G., Ocampo-García B.E., León-Rodriguez L.M., Santos-Cuevas C.L., García-Becerra R., Medina L.A., Gómez-Oliván L. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. Bioconjugate Chem 2011, 22:913-922.
117. Zhang X.D., Wu D., Shen X., Chen J., Sun Y.-M., Liu P.-X., Liang X.-J. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012, 33:6408-6419.
118. Cobley C.M., Au L., Chen J., Xia Y. Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery. Expert Opin Drug Deliv 2010, 7:577-587.
119. Haba Y., Kojima C., Harada A., et al. Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability. Langmuir 2007, 23:5243-5246.
120. Kang H., Jia B., Li J., Morrish D., Gu M. Enhanced photothermal therapy assisted with gold nanorods using a radially polarized beam. Appl Phys Lett 2010, 96:063702. 10.1063/1.3302461.
121. Wu X., Ming T., Wang X., Wang P., Wang J., Chen J. High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. ACS Nano 2010, 4:113-120.
122. Park G.S., Kwon H., Kwak D.W., Park S.Y., Kim M., Lee J.H., et al. Correction to full surface embedding of gold clusters on silicon nanowires for efficient capture and photothermal therapy of circulating tumor cells. Nano Lett 2012, 12:1638-1642.
123. Stern J.M., Stanfield J., Kabbani W., Hsieh J.T., Cadeddu J.R.A. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008, 179:748-753.
124. Khaing Oo M.K., Yang Y., Hu Y., Gomez M., Du H., Wang H. Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. ACS Nano 2012, 6:1939-1947.
125. Kuo W.S., Chang Y.T., Cho K.C., Chiu K.C., Lien C.H., Yeh C.S., Chen S.J. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX Au-photosensitizer conjugates. Biomaterials 2012, 33:3270-3278.
126. Wang L., Yang W., Read P., Larner J., Sheng K. Tumor cell apoptosis induced by nanoparticle conjugate in combination with radiation therapy. Nanotechnology 2010, 21:475103. 10.1088/0957-4484/21/47/475103.
127. Xiao L., Gu L., Howell S.B., Sailor M.J. Porous silicon nanoparticle, photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano 2011, 5:3651-3659.
128. Cai W., Gao T., Hong H., Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotech Sci Appl 2008, 1:17-32.
129. Lowery A.R., Gobin A.M., Day E.S., Halas N.J., West J.L. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 2006, 1:149-154.
130. Huang X., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006, 128:2115-2120.
131. Chen J., Wang D., Xi J., Au L., Siekkinen A., Warsen A., et al. Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett 2007, 1318-1322.
132. Bernardi R.J., Lowery A.R., Thompson P.A., Blaney S.M., West J.L. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol 2008, 86:165-172.
133. Au L., Zhang Q., Cobley C.M., Gidding M., Schwartz A.G., Chen J., et al. Quantifying the cellular uptake of antibody-conjugated au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry. ACS Nano 2010, 4:35-42.
134. Raoof M., Stuart J., Kaluarachchi W.D., Massey K.L., Briggs K., Zhu C., Cheney M.A., Wilson L.J., Curley S.A. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequency-based cancer therapy. Nanomedicine 2012, 8:1096-1105.
135. Unaka G., Ozkayab F., Medineb E.I., Kozgusb O., Sakaryac S., Bekisd R., et al. Gold nanoparticle probes: design and in vitro applications in cancer cell culture. Colloids Surf B Biointerfaces 2012, 90:217-226.
136. Mocellin S., Nitti D. TNF and cancer: the two sides of the coin. Front Biosci 2008, 13:2774-2783.
137. Visaria R.K., Griffin R.J., Williams B.W., Ebbini E.S., Paciotti G.F., Song C.W., et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor alpha delivery. Mol Cancer Ther 2006, 5:1014-1020.
138. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004, 11:169-183.
139. Dhar S., Daniel W.L., Giljohann D.A., Mirkin C.A., Lippard S.J. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. J Am Chem Soc 2009, 131:14652-14653.
140. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007, 4:713-722.
141. Dixit V., Van den Bossche J., Sherman D.M., Thompson D.H., Andres R.P. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells. Bioconjug Chem 2006, 17:603-609.
142. Shi X., Wang S., Meshinchi S., Van Antwerp M.E., Bi X., Lee I., et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007, 3:1245-1252.
143. Chanda N., Kattumuri V., Shukla R., Zambre A., Katti K., Upendran A. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. PNAS 2010, 107:8760-8765.
144. Wang R., Billone P.S., Mullett W.M. Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials. J Nanomaterials 2013, Article ID 629681. doi:10.1155/2013/629681.
145. Etheridge M.L., Campbell S.A., Erdman A.G., Haynes C.L., Wolf S.M., McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine: NBM 2013, 9:1-14.